|
6160
|
Beigene Ltd
|
2.04%
|
HK
|
HK
|
|
DXCM
|
DexCom, Inc.
|
1.86%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
1.79%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
1.79%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
1.77%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
1.75%
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
1.70%
|
US
|
NASDAQ
|
|
ISRG
|
Intuitive Surgical, Inc.
|
1.62%
|
US
|
NASDAQ
|
|
MRK
|
Merck & Company, Inc.
|
1.61%
|
US
|
NYSE
|
|
BSX
|
Boston Scientific Corporation
|
1.55%
|
US
|
NYSE
|
|
A
|
Agilent Technologies, Inc.
|
1.53%
|
US
|
NYSE
|
|
NVCR
|
NovoCure Limited
|
1.52%
|
US
|
NASDAQ
|
|
PEN
|
Penumbra, Inc.
|
1.47%
|
US
|
NYSE
|
|
ARGX
|
Argen-X
|
1.45%
|
BE
|
BR
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
1.43%
|
US
|
NASDAQ
|
|
ABBV
|
AbbVie Inc.
|
1.43%
|
US
|
NYSE
|
|
QGEN
|
Qiagen N.V.
|
1.39%
|
US
|
NYSE
|
|
HOLX
|
Hologic, Inc.
|
1.39%
|
US
|
NASDAQ
|
|
068270
|
Celltrion Inc
|
1.36%
|
KR
|
KO
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
1.35%
|
US
|
NASDAQ
|